NexgenRX Inc.
Research NexgenRX Inc. (NXG) on Bullrun: market cap CAD 43.38M, P/E 20.3, dividend yield 3.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerNXG
- ExchangeV
- CountryCanada
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyCAD
- Market capCAD 43.38M
- P/E20.3
- Dividend yield3.3%
- Financial periodQ1 2026
- RevenueCAD 5.00M
- Net incomeCAD 1.23M
- Free cash flowCAD 45.41K
- Gross margin85.1%
Valuation Snapshot
latest market cap is CAD 43.38M; P/E is 20.3; dividend yield is 3.3%.
Peer valuation comparison
Latest P/E is 20.33x versus a Healthcare sector median of 23.44x (13.2% below).
Latest dividend yield is 3.28% versus a Healthcare sector median of 2.01% (62.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CAD 6.90B | CAD 898.00M | CAD 1.10B | 44.1% | 7.45 | CAD 60.20M | CAD 96.00M | CAD 1.78B |
| FY2024 | CAD 6.12B | CAD 743.20M | CAD 1.00B | 43.2% | 6.06 | CAD 171.30M | CAD 60.60M | CAD 1.75B |
| FY2023 | CAD 5.49B | CAD 800.50M | CAD 983.30M | 44.1% | 6.56 | CAD 124.30M | CAD 88.20M | CAD 1.64B |
| FY2022 | CAD 5.03B | CAD 710.70M | CAD 593.70M | 43.2% | 5.71 | CAD 2.70M | CAD 102.30M | CAD 1.17B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-09-15 | CAD 43.38M | 20.3 | 3.3% | 0.02 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.02 CAD, yield 3.3%.
About NexgenRX Inc.
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides proprietary computer software, and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is NexgenRX Inc.'s market cap?
NexgenRX Inc.'s market capitalization is CAD 43.38M.
What is NexgenRX Inc.'s P/E ratio?
NexgenRX Inc.'s price-to-earnings (P/E) ratio is 20.3.
Does NexgenRX Inc. pay a dividend?
NexgenRX Inc. has a dividend yield of 3.3%.
What does NexgenRX Inc. do?
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. It also provides proprietary computer software, and ancillary services. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.